These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 1902508)

  • 1. Radioimmunodetection of neuroblastoma with iodine-131-3F8: correlation with biopsy, iodine-131-metaiodobenzylguanidine and standard diagnostic modalities.
    Yeh SD; Larson SM; Burch L; Kushner BH; Laquaglia M; Finn R; Cheung NK
    J Nucl Med; 1991 May; 32(5):769-76. PubMed ID: 1902508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
    Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iodine-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma.
    Shulkin BL; Shapiro B; Hutchinson RJ
    J Nucl Med; 1992 Oct; 33(10):1735-40. PubMed ID: 1403138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans.
    Gordon I; Peters AM; Gutman A; Morony S; Dicks-Mireaux C; Pritchard J
    J Nucl Med; 1990 Feb; 31(2):129-34. PubMed ID: 2313350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 131I-MIBG in the diagnosis of primary and metastatic neuroblastoma.
    El-Maghraby T
    Gulf J Oncolog; 2007 Jul; (2):33-41. PubMed ID: 20084722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disaloganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastoma.
    Kramer K; Gerald WL; Kushner BH; Larson SM; Hameed M; Cheung NK
    Med Pediatr Oncol; 2001 Jan; 36(1):194-6. PubMed ID: 11464881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of iodine-123 meta-iodobenzylguanidine scintigraphy and single bone marrow aspiration biopsy in the diagnosis and follow-up of 26 children with neuroblastoma.
    Osmanagaoglu K; Lippens M; Benoit Y; Obrie E; Schelstraete K; Simons M
    Eur J Nucl Med; 1993 Dec; 20(12):1154-60. PubMed ID: 8299650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of stage 4 neuroblastoma patients by means of MIBG and 99mTc-MDP scintigraphy.
    Turba E; Fagioli G; Mancini AF; Rosito P; Galli A; Alvisi P
    J Nucl Biol Med (1991); 1993 Sep; 37(3):107-14. PubMed ID: 8218456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The place of 99mTc-MDP skeletal scintigraphy in neuroblastoma. Is a new assessment necessary?].
    Sautter-Bihl ML; Bihl H; Heinze HG
    Nuklearmedizin; 1991 Feb; 30(1):7-12. PubMed ID: 2062676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iodine-131 metaiodobenzylguanidine scintigraphy for the location of neuroblastoma: preliminary experience in ten cases.
    Geatti O; Shapiro B; Sisson JC; Hutchinson RJ; Mallette S; Eyre P; Beierwaltes WH
    J Nucl Med; 1985 Jul; 26(7):736-42. PubMed ID: 4009283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Indications for MIBG scintigraphy in the diagnosis of neuroblastoma].
    Hausegger KA; Fueger GF; Ebner F; Urban C
    Nuklearmedizin; 1989 Feb; 28(1):34-40. PubMed ID: 2710644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of 131 iodine-metaiodobenzylguanidine scanning in the correlative imaging of patients with neuroblastoma.
    Andrich MP; Shalaby-Rana E; Movassaghi N; Majd M
    Pediatrics; 1996 Feb; 97(2):246-50. PubMed ID: 8584386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assessment of the biological activity of residual or recurrent neuroblastoma tumors with 131I-metaiodobenzylguanidine (MIBG) scintigraphy].
    Murashima S; Takeda K; Okuda Y; Nakagawa T; Sakurai M
    Kaku Igaku; 1990 Dec; 27(12):1393-400. PubMed ID: 2290210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical use of 131I-meta-iodo-benzylguanidine (MIBG) for the diagnosis of neuroblastoma.
    Zagar I; Mitrović S; Adanja G; Maksimović L; Ivanovski P; Han R; Kovacić K
    Med Pregl; 1993; 46 Suppl 1():74-5. PubMed ID: 8569615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Scintigraphy with radioiodinated meta-iodobenzylguanidine in the diagnosis of neuroblastoma].
    Müller-Gärtner HW; Erttmann R; Helmke K
    Nuklearmedizin; 1985 Dec; 24(5-6):222-6. PubMed ID: 3912731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total-body scintigraphy with 131I-meta-iodobenzylguanidine for detection of neuroblastoma.
    Hoefnagel CA; Voûte PA; de Kraker J; Marcuse HR
    Diagn Imaging Clin Med; 1985; 54(1):21-7. PubMed ID: 3918823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of I-131 metaiodobenzylguanidine (MIBG) imaging in suspected neuroblastoma].
    Iwashita S; Nakajo M; Nakabeppu Y; Tanoue T; Yonekura R; Taguchi M; Shimabukuro K; Shinohara S; Sakata H
    Kaku Igaku; 1989 Sep; 26(9):1135-47. PubMed ID: 2810911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 99mTc-monoclonal antibody radiolabeled via hydrazino nicotinamide derivative for imaging disialoganglioside G(D2)-positive tumors.
    Fonti R; Cheung NK; Bridger GJ; Guo HF; Abrams MJ; Larson SM
    Nucl Med Biol; 1999 Aug; 26(6):681-6. PubMed ID: 10587107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radionuclide diagnosis and therapy of neural crest tumors using iodine-131 metaiodobenzylguanidine.
    Hoefnagel CA; Voûte PA; de Kraker J; Marcuse HR
    J Nucl Med; 1987 Mar; 28(3):308-14. PubMed ID: 3102701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of neuroblastoma using 131I-meta-iodobenzylguanidine.
    Edeling CJ; Büchler Frederiksen P; Kamper J; Jeppesen P
    Nuklearmedizin; 1986 Oct; 25(5):172-5. PubMed ID: 3797256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.